Vertex Pharmaceuticals, Inc. VRTX: $207.15

50 Northern Avenue, Boston, MA, US. | Sector: Health Technology | Exchange: NASDAQ | Web: http://www.vrtx.com

  • Market Cap$55.11B
  • Next Earning Date2020-10-29
  • Change (52 Weeks)8.80%
  • Low (52 Weeks)$189.35
  • iTradely Smart Advisor recommends that you allocate 4.60% of your total portfolio to Vertex Pharmaceuticals, Inc.

    Analysts' Price Target


    HighLowAverage
    $340$245$306.91
    $306.91 Last Updated: 2020-10-14 00:00:00
    The target above is the Average Price target set by the institutional analysts where High Estimate is $340, Median $309 and Low $245.

    Analyst Rating


    Moderate Buy

    Based on 26 Institutional Analyst Ratings where 69.23% are on Strong Buy, 3.85% on Moderate Buy, 26.92% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Analysts' Recommendations


    Analyst
    Recommendation
    Action
    Morgan StanleyEqual-WeightMaintained
    SVB LeerinkMarket PerformMaintained
    Morgan StanleyEqual-WeightMaintained
    SVB LeerinkMarket PerformMaintained
    SVB LeerinkMarket PerformMaintained
    HC Wainwright & Co.BuyMaintained
    Cantor FitzgeraldOverweightMaintained
    Credit SuisseOutperformMaintained
    Morgan StanleyEqual-WeightDowngraded
    SunTrust Robinson HumphreyBuyMaintained
    CitigroupBuyMaintained
    Argus ResearchBuyMaintained
    CitigroupBuyMaintained
    SVB LeerinkMarket PerformMaintained
    StifelBuyMaintained
    OppenheimerOutperformMaintained
    Morgan StanleyOverweightMaintained
    JMP SecuritiesMarket OutperformMaintained
    HC Wainwright & Co.BuyMaintained
    GuggenheimBuyMaintained
    CFRABuyMaintained
    BMO CapitalOutperformMaintained
    RBC CapitalSector PerformDowngraded
    Morgan StanleyOverweightMaintained
    Cantor FitzgeraldOverweightReiterated
    Stifel NicolausBuyMaintained
    RBC CapitalOutperformMaintained
    Morgan StanleyOverweightMaintained
    Credit SuisseOutperformMaintained
    CFRABuyMaintained
    BairdNeutralDowngraded
    B of A SecuritiesBuyMaintained
    OppenheimerOutperformMaintained
    PiperJaffrayOverweightMaintained
    JP MorganOverweightMaintained
    Bank of AmericaBuyReiterated
    Cantor FitzgeraldOverweightMaintained
    SunTrust Robinson HumphreyBuyInitiated
    Stifel NicolausBuyMaintained
    Piper JaffrayOverweightMaintained
    Morgan StanleyOverweightMaintained
    CitigroupBuyMaintained
    Morgan StanleyOverweightMaintained
    Goldman SachsBuyReiterated
    Stifel NicolausBuyMaintained
    Piper JaffrayOverweightMaintained
    NeedhamHoldDowngraded
    Credit SuisseOutperformMaintained
    Credit SuisseOutperformInitiated
    Evercore ISI GroupIn-LineInitiated
    William BlairOutperformUpgraded
    SVB LeerinkMarket PerformDowngraded
    OppenheimerOutperformMaintained
    CitigroupBuyMaintained
    Raymond JamesMarket PerformDowngraded
    Morgan StanleyOverweightMaintained
    H.C. WainwrightBuyUpgraded
    Raymond JamesOutperformMaintained
    BMO CapitalOutperformMaintained
    Cantor FitzgeraldOverweightInitiated
    CitigroupBuyMaintained
    UBSNeutralMaintained
    Morgan StanleyOverweightMaintained
    Morgan StanleyOverweightMaintained
    Maxim GroupBuyMaintained
    JMP SecuritiesMarket OutperformMaintained
    Credit SuisseOutperformMaintained
    Morgan StanleyOverweightMaintained
    BMO CapitalOutperformMaintained
    BarclaysOverweightMaintained
    Bank of AmericaBuyMaintained
    Bank of AmericaBuyUpgraded
    Deutsche BankBuyInitiated
    DA DavidsonBuyInitiated
    RBC CapitalOutperformInitiated
    Raymond JamesOutperformUpgraded
    Janney CapitalBuyUpgraded
    Cowen & Co.OutperformUpgraded
    CitigroupBuyMaintained
    BarclaysOverweightUpgraded
    JefferiesBuyInitiated
    NeedhamBuyUpgraded
    OppenheimerOutperformUpgraded
    BMO CapitalOutperformUpgraded
    JMP SecuritiesMarket OutperformUpgraded
    OppenheimerPerformInitiated
    BarclaysEqual-WeightDowngraded
    Janney CapitalNeutralInitiated
    William BlairMarket PerformDowngraded
    H.C. WainwrightNeutralDowngraded
    JefferiesBuyMaintained
    JefferiesBuyMaintained
    Raymond JamesMarket PerformInitiated
    Morgan StanleyOverweightMaintained
    Goldman SachsNeutralDowngraded
    Credit SuisseOutperformMaintained
    BMO CapitalMarket PerformInitiated
    Leerink SwannOutperformMaintained
    Leerink SwannOutperformInitiated
    JefferiesBuyUpgraded
    BarclaysOverweightMaintained
    JP MorganOverweightMaintained
    BarclaysOverweightMaintained
    Credit SuisseOutperformInitiated
    Stifel NicolausBuyInitiated
    H.C. WainwrightBuyUpgraded
    Morgan StanleyOverweightUpgraded
    ArgusBuyUpgraded
    BarclaysOverweightUpgraded
    JefferiesHoldInitiated
    JMP SecuritiesMarket OutperformMaintained
    Leerink SwannOutperformMaintained
    Bank of AmericaNeutralMaintained
    RBC CapitalOutperformMaintained
    CitigroupBuyMaintained
    Canaccord GenuityBuyInitiated
    Maxim GroupHoldMaintained
    Credit SuisseBuyMaintained
    CitigroupBuyMaintained
    BTIG ResearchBuyInitiated
    BarclaysEqual-weightInitiated
    JMP SecuritiesMarket OutperformMaintained
    JMP SecuritiesMarket PerformMaintained
    PiperJaffrayOverweightUpgraded
    GuggenheimBuyInitiated
    Deutsche BankBuyMaintained
    Deutsche BankBuyMaintained
    Goldman SachsBuyUpgraded
    OppenheimerMarket PerformInitiated
    UBSBuyMaintained
    H.C. WainwrightNeutralDowngraded
    CitigroupBuyMaintained
    UBSBuyUpgraded
    Goldman SachsNeutralMaintained
    Summer StreetNeutralDowngraded
    OppenheimerOutperformInitiated
    UBSNeutralDowngraded
    WunderlichBuyInitiated
    UBSBuyMaintained
    Morgan StanleyEqual-WeightMaintained
    Goldman SachsNeutralUpgraded
    Deutsche BankBuyMaintained
    CitigroupBuyMaintained
    Canaccord GenuityBuyUpgraded
    Canaccord GenuityHoldInitiated
    JP MorganOverweightMaintained
    LazardNeutralDowngraded
    BarclaysOverweightMaintained
    Janney CapitalBuyInitiated
    Deutsche BankBuyMaintained
    ArgusDowngraded
    Credit SuisseNeutralDowngraded
    Goldman SachsSellDowngraded
    Credit SuisseOutperformMaintained
    Deutsche BankBuyInitiated
    ArgusBuyInitiated
    UBSBuyMaintained
    PiperJaffrayNeutralDowngraded
    Goldman SachsNeutralMaintained
    CitigroupBuyMaintained
    Bank of AmericaBuyMaintained
    JP MorganOverweightUpgraded
    Goldman SachsNeutralMaintained
    Morgan StanleyEqual-WeightUpgraded
    Brean CapitalBuyUpgraded
    ISI GroupBuyUpgraded
    UBSNeutralMaintained
    UBSNeutralMaintained
    Morgan StanleyUnderweightDowngraded
    Bank ofericaBuyMaintained

    Techical Analysis


    Sell

    Based on 17 Technical Indicators where 23.53% are on Buy, 47.06% on Sell, and 29.41% Neutral.

    Earning Per Share (EPS) Estimate


    $2.34
    The consensus EPS was reported on 2020-10-29 and is based on 21 Analyst's estimates for Q3 2020 ending on 2020-09-30.

    Last Quarter


    Actual
    Estimate
    Date
    $2.61$2.08Q2 2020


    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $2.61$2.08Q2 2020
    $2.56$1.87Q1 2020
    $1.7$1.21Q4 2019
    $1.23$1.15Q3 2019

    Investor Sentiment


    Moderately Positive

    Based on 106,316 investor portfolio.

    News Sentiment


    Bullish

    Based on 17 articles published Last Week, where 100.00% are Bullish and 0.00% are Bearish.

    Latest News About Vertex Pharmaceuticals, Inc.

    Learn More About Analyst Ratings & Price Targets

    The best way to get an overall picture of how a stock is performing is through Analyst Ratings. The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).

    Stock Sentiments can be found in websites like StockTwits and iTradely's Stock Research Tools . The Brain Company also provides Premium Stock Sentiment data for investors.